Clinical Trials Browser

Phase 2 × Erlotinib Hydrochloride × 90 days × Clear all

Hereditary leiomyomatosis and renal cell cancer, Papillary renal cell carcinoma, sporadic, Carcinoma, Renal Cell

Lymphoma, Non-Hodgkin, Multiple Myeloma

Clinical Trials